Medpace Holdings earnings were $460.4M for the trailing 12 months ending Mar 31, 2026, with 20.1% growth year over year. The latest MEDP earnings report on Mar 31, 2026 announced Q1 2026 earnings of $123.9M, down 8.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, MEDP reported annual earnings of $451.1M, with 11.6% growth.
MEDP past earnings growth
How has MEDP's earnings growth performed historically?
What were Medpace Holdings's earnings last quarter?
On MEDP's earnings call on Invalid Date, Medpace Holdings (NASDAQ: MEDP) reported Q1 2026 earnings per share (EPS) of $4.35, up 15.38% year over year. Total MEDP earnings for the quarter were $123.87 million. In the same quarter last year, Medpace Holdings's earnings per share (EPS) was $3.77.
As of the last Medpace Holdings earnings report, Medpace Holdings is currently profitable. Medpace Holdings's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $460.40 million, a 10.57% increase year over year.
What was MEDP's earnings growth in the past year?
As of Medpace Holdings's earnings date in Invalid Date, Medpace Holdings's earnings has grown 20.06% year over year. This is 9.54 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.52%. MEDP earnings in the past year totalled $460.40 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.